Pharmaceutical Associates Inc. is recalling 7,416 bottles of Nystatin Oral Suspension, USP (100,000 units per mL), an antifungal medication used to treat yeast infections in the mouth. The recall was initiated because testing showed the drug is subpotent, meaning it contains less of the active ingredient than required. This cherry/peppermint flavored medication was distributed nationwide in 16 fl oz (473 mL) bottles. Consumers should check their medicine cabinets for the specific lot number BE85 to determine if their product is affected.
Because the medication is subpotent, it may not effectively treat the fungal infection as intended. This could lead to a prolonged infection or the worsening of symptoms because the patient is not receiving the full prescribed dose of the antifungal agent.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.